Ms Grace Lim, the PhD student under our Thyroid Cancer TCE (Translational Centre of Excellence), was awarded a Sydney Vital Travel Grant to attend and present her research study at this year’s annual meeting of the American Thyroid Association.
Dr Andrew Care has been a member of Sydney Vital since 2017 and this year was awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
The annual NSW Premier’s Awards are back.
Hosted by the Cancer Institute NSW, this year the Awards will recognise the achievements of individuals and teams that work in cancer research across NSW and showcase the outstanding work they have put in to lessen the impact of cancer.
Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.
This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.
Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please let us know if you have any further questions.
Email: [email protected] for general information regarding your application submission.
Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
|1||Jerikho Bulanadi||Kolling Institute of Medical Research||Prof Ross Smith||Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.||$15,000|
|2||Emma Colvill||Sydney University Medical School||Prof Paul Keall||The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer||$15,000|
|3||Grace Gifford||Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney||Dr William Stevenson||Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.||$15,000|
|4||Dr Anthony Glover||Kolling Institute of Medical Research, Royal North Shore Hospital||Prof Stanley Sidhu||Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.||$15,000|
|5||Diana Hatoum||Faculty of Science, UTS Sydney||Dr Najah Nassif||A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.||$15,000|
|6||Samuel Brennan||Faculty of Science, UTS Sydney||Dr Rose Martiniello-Wilks||Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.||$15,000|
|7||Ben Harris||Sydney Medical School, University of Sydney||Dr Kellie Charles||Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.||$15,000|
|8||Adrian Lee||Bill Walsh Translation Cancer Research Laboratory, Kolling Institute||Dr Viive Howell||"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with|
|9||Jaynish Shah||Sydney Medical School, University of Sydney||Prof Deborah Marsh||Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?||$15,000|